Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

InVivo Therapeutics Corp Company Overview 5

InVivo Therapeutics Corp Company Snapshot 5

InVivo Therapeutics Corp Pipeline Products and Ongoing Clinical Trials Overview 5

InVivo Therapeutics Corp – Pipeline Analysis Overview 7

InVivo Therapeutics Corp - Key Facts 7

InVivo Therapeutics Corp - Major Products and Services 8

InVivo Therapeutics Corp Pipeline Products by Development Stage 9

InVivo Therapeutics Corp Pipeline Products Overview 11

Dural Graft 11

Dural Graft Product Overview 11

Injectable Hydrogel - Fibrosis 12

Injectable Hydrogel - Fibrosis Product Overview 12

Injectable Hydrogel - Peripheral Nerve Pain 13

Injectable Hydrogel - Peripheral Nerve Pain Product Overview 13

Injectable Hydrogel Device - Acute SCI 14

Injectable Hydrogel Device - Acute SCI Product Overview 14

InVivoSeal 15

InVivoSeal Product Overview 15

Nerve Conduit 16

Nerve Conduit Product Overview 16

Neuro-Spinal Scaffold - Acute Complete Cervical SCI 17

Neuro-Spinal Scaffold - Acute Complete Cervical SCI Product Overview 17

Neuro-Spinal Scaffold - Acute Complete Thoracic SCI 18

Neuro-Spinal Scaffold - Acute Complete Thoracic SCI Product Overview 18

Neuro-Spinal Scaffold - Incomplete Thoracic & Cervical SCI 19

Neuro-Spinal Scaffold - Incomplete Thoracic & Cervical SCI Product Overview 19

Spinal Multi - Segmental Cell and Drug Delivery System 20

Spinal Multi - Segmental Cell and Drug Delivery System Product Overview 20

TrailMaker 21

TrailMaker Product Overview 21

InVivo Therapeutics Corp - Key Competitors 22

InVivo Therapeutics Corp - Key Employees 23

InVivo Therapeutics Corp - Locations And Subsidiaries 24

Head Office 24

Recent Developments 25

InVivo Therapeutics Corp, Recent Developments 25

May 02, 2018: InVivo Therapeutics Announces Presentation of Complete Six-Month Primary Endpoint Results from the INSPIRE Study of the Investigational Neuro-Spinal Scaffold in Acute Thoracic Complete Spinal Cord Injury 25

Mar 19, 2018: InVivo Therapeutics Announces Contemporary Thoracic SCI Registry Study (the “CONTEMPO Registry Study”) Findings 25

Mar 08, 2018: InVivo Therapeutics Receives FDA Approval for Pivotal, Randomized, Controlled Trial of the Neuro-Spinal Scaffold in Patients with Acute Spinal Cord Injury 26

Feb 05, 2018: InVivo Therapeutics Announces Appointment of Richard Toselli, M.D., as President and Chief Executive Officer 26

Jan 03, 2018: InVivo Therapeutics Announces Latest Results from INSPIRE and Provides Update on Proposed Clinical Path Forward 27

Oct 10, 2017: InVivo Therapeutics Announces Oral Platform Presentation at 2017 Congress of Neurological Surgeons Annual Meeting 27

Sep 05, 2017: InVivo Therapeutics Announces Publication in Neurosurgery of Lifetime Hospitalization Costs for Thoracic Spinal Cord Injury Patients by Severity Grade 28

Aug 28, 2017: InVivo Therapeutics Announces Strategic Corporate Restructuring 28

Jul 31, 2017: InVivo Therapeutics Announces Updates on the INSPIRE Study 28

Jul 12, 2017: InVivo Therapeutics Announces Stanford Medicine as New Site for INSPIRE Study 30

Appendix 32

Methodology 32

About GlobalData 35

Contact Us 35

Disclaimer 35

Summary

InVivo Therapeutics Corp (InVivo), a subsidiary of InVivo Therapeutics Holdings Corp, is a medical device company that offers therapeutic products. The company develops and commercializes groundbreaking treatments for spinal cord injuries. Its products include biocompatible neuro spinal scaffold to treat acute SCI, and a biocompatible neuro spinal scaffold plus stem cells to treat chronic. InVivo offers treatment for mechanical injury directly disrupts axons, blood vessels, and cell membranes; and compressive-contusive-type injuries. The company provides services in the field of spinal cord injury. Its pipeline products comprise neuro-spinal scaffold, and bioengineered neural trails. InVivo is headquartered in Cambridge, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company InVivo Therapeutics Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company